Lundholm et al.77 have demonstrated that prostate cancer-derived exosomes downregulate the expression of NKG2D in NK and CD8+ T cells, thus decreasing NKG2D-mediated cytotoxicity and promoting immune suppression and tumor escape. Here, KLRK1 is linked to prostate carcinoma.